Literature DB >> 15566332

Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.

Wivine Burny1, Corinne Liesnard, Catherine Donner, Arnaud Marchant.   

Abstract

Cytomegalovirus is the most common cause of congenital infection. Congenital cytomegalovirus infection can follow both primary and recurrent maternal infections. It is associated with a significant burden of disease and death. The determinants of mother-to-child transmission and the pathogenesis of symptomatic fetal infection remain poorly understood. For a long time, congenital cytomegalovirus infection has been a neglected disease. Recently, the Institute of Medicine has recognized that the development of a vaccine against congenital cytomegalovirus infection is a public health priority, which should stimulate research in this area. The development of antiviral therapies to prevent symptoms in infected newborns also represents an important area of research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566332     DOI: 10.1586/14789072.2.6.881

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  17 in total

1.  UL26 Attenuates IKKβ-Mediated Induction of Interferon-Stimulated Gene (ISG) Expression and Enhanced Protein ISGylation during Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.

Authors:  Ranjit I Kylat; Edmond N Kelly; Elizabeth Lee Ford-Jones
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

Review 3.  Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.

Authors:  Chad D Williamson; Roberta L DeBiasi; Anamaris M Colberg-Poley
Journal:  Infect Disord Drug Targets       Date:  2012-02

4.  Inhibition of calmodulin-dependent kinase kinase blocks human cytomegalovirus-induced glycolytic activation and severely attenuates production of viral progeny.

Authors:  Jessica McArdle; Xenia L Schafer; Joshua Munger
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

Review 5.  The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

Authors:  A Louise McCormick; Edward S Mocarski
Journal:  Cell Mol Immunol       Date:  2014-12-29       Impact factor: 11.530

6.  Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylation.

Authors:  Stefanie Renee DeVito; Emilio Ortiz-Riaño; Luis Martínez-Sobrido; Joshua Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-03       Impact factor: 11.205

7.  Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication.

Authors:  Cody M Spencer; Xenia L Schafer; Nathaniel J Moorman; Joshua Munger
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

8.  Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy.

Authors:  Joshua Munger; Bryson D Bennett; Anuraag Parikh; Xiao-Jiang Feng; Jessica McArdle; Herschel A Rabitz; Thomas Shenk; Joshua D Rabinowitz
Journal:  Nat Biotechnol       Date:  2008-09-28       Impact factor: 54.908

9.  HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication.

Authors:  Jessica McArdle; Nathaniel J Moorman; Joshua Munger
Journal:  PLoS Pathog       Date:  2012-01-26       Impact factor: 6.823

Review 10.  The pathogenesis of microcephaly resulting from congenital infections: why is my baby's head so small?

Authors:  L D Frenkel; F Gomez; F Sabahi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.